Literature DB >> 12477820

Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).

Joanna Pfeuffer1, Karen Püschel, Volker ter Meulen, Jürgen Schneider-Schaulies, Stefan Niewiesk.   

Abstract

Infection of humans with wild-type measles virus leads to strong immune suppression and secondary infections, whereas immunization with an attenuated vaccine strain does not. Using the cotton rat model (Sigmodon hispidus), we investigated whether vaccine and wild-type viruses differ in viral spread and whether this is correlated with inhibition of of proliferation of spleen cells ex vivo after mitogen stimulation. After intranasal infection of cotton rats with wild-type and vaccine strains, it was found that wild-type virus replicates better in lung tissue, spreads to the mediastinal lymph nodes, and induces a more pronounced and longer-lasting inhibition of proliferation of spleen cells ex vivo after mitogen stimulation than does vaccine virus. To induce the same degree of proliferation inhibition, 1,000-fold less wild-type virus was required than vaccine virus. With this system, the virulence of various measles virus isolates and recombinant viruses was tested. Four (in humans and/or monkeys) highly pathogenic virus strains were immunosuppressive, whereas viruses of vaccine virus genotype A were not. Using virus pairs which, due to passage on fibroblasts versus lymphoid cells or due to a point mutation in the hemagglutinin (N481 --> Y), differed in their usage of the two receptor molecules CD46 and CD150 on human cells, it was found that viruses using exclusively CD150 in vitro spread to mediastinal lymph nodes and induced strong immune suppression. These data demonstrate that important parameters of virulence seen in humans, such as viral spread and immune suppression, are reflected in the cotton rat model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477820      PMCID: PMC140581          DOI: 10.1128/jvi.77.1.150-158.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.

Authors:  S Niewiesk; I Eisenhuth; A Fooks; J C Clegg; J J Schnorr; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture.

Authors:  B K Rima; J A Earle; K Baczko; V ter Meulen; U G Liebert; C Carstens; J Carabaña; M Caballero; M L Celma; R Fernandez-Muñoz
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

Review 3.  Clinical spectrum of measles.

Authors:  M Katz
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 4.  Immune responses during measles virus infection.

Authors:  D E Griffin
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

5.  A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice.

Authors:  M Singh; R Cattaneo; M A Billeter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.

Authors:  J Schlender; J J Schnorr; P Spielhoffer; T Cathomen; R Cattaneo; M A Billeter; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Differential downregulation of CD46 by measles virus strains.

Authors:  J Schneider-Schaulies; L M Dunster; F Kobune; B Rima; V ter Meulen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures.

Authors:  K Shibahara; H Hotta; Y Katayama; M Homma
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

9.  Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.

Authors:  J Schneider-Schaulies; J J Schnorr; U Brinckmann; L M Dunster; K Baczko; U G Liebert; S Schneider-Schaulies; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Nonhuman primate models of measles.

Authors:  F Kobune; H Takahashi; K Terao; T Ohkawa; Y Ami; Y Suzaki; N Nagata; H Sakata; K Yamanouchi; C Kai
Journal:  Lab Anim Sci       Date:  1996-06
View more
  18 in total

1.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

2.  Self-assembly Stability Compromises the Efficacy of Tryptophan-Containing Designed Anti-measles Virus Peptides.

Authors:  Diogo A Mendonça; Tiago N Figueira; Manuel N Melo; Olivia Harder; Stefan Niewiesk; Anne Moscona; Matteo Porotto; Ana Salomé Veiga
Journal:  J Nanomed Nanotechnol       Date:  2019-03-12

3.  Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection.

Authors:  M Gia Green; Natasha Petroff; Krista M D La Perle; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

4.  Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.

Authors:  Cecilia Frecha; Camille Lévy; Caroline Costa; Didier Nègre; Fouzia Amirache; Robin Buckland; Steven J Russell; François-Loïc Cosset; Els Verhoeyen
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

6.  Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.

Authors:  Dhohyung Kim; Luis Martinez-Sobrido; Changsun Choi; Natasha Petroff; Adolfo García-Sastre; Stefan Niewiesk; Thomas Carsillo
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

7.  Measles virus neurovirulence and host immunity.

Authors:  Michael Oglesbee; Stefan Niewiesk
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

8.  Cytokine imbalance after measles virus infection has no correlation with immune suppression.

Authors:  Mary Carsillo; Kay Klapproth; Stefan Niewiesk
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

9.  Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats.

Authors:  Dhohyung Kim; Stefan Niewiesk
Journal:  Vaccine       Date:  2013-11-18       Impact factor: 3.641

10.  Canine distemper viruses expressing a hemagglutinin without N-glycans lose virulence but retain immunosuppression.

Authors:  Bevan Sawatsky; Veronika von Messling
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.